3K5G
Human bace-1 complex with bjc060
Summary for 3K5G
Entry DOI | 10.2210/pdb3k5g/pdb |
Related | 3K5C 3K5D 3K5F |
Descriptor | Beta-secretase 1, (1R,3S)-N-[(1S,2R)-1-benzyl-2-hydroxy-3-{[3-(1-methylethyl)benzyl]amino}propyl]-3-[1-methyl-1-(2-oxopiperidin-1-yl)ethyl]cyclohexanecarboxamide (3 entities in total) |
Functional Keywords | aspartyl protease, alzheimer's disease, structure-based design, disulfide bond, endoplasmic reticulum, endosome, glycoprotein, golgi apparatus, hydrolase-hydrolase inhibitor complex, membrane, protease, transmembrane, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (human) |
Cellular location | Membrane; Single-pass type I membrane protein: P56817 |
Total number of polymer chains | 3 |
Total formula weight | 136017.40 |
Authors | Rondeau, J.-M. (deposition date: 2009-10-07, release date: 2010-05-05, Last modification date: 2017-11-01) |
Primary citation | Hanessian, S.,Shao, Z.,Betschart, C.,Rondeau, J.M.,Neumann, U.,Tintelnot-Blomley, M. Structure-based design and synthesis of novel P2/P3 modified, non-peptidic beta-secretase (BACE-1) inhibitors. Bioorg.Med.Chem.Lett., 20:1924-1927, 2010 Cited by PubMed: 20172717DOI: 10.1016/j.bmcl.2010.01.139 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report